BioXcel Therapeutics Statistics

Total Valuation

BTAI has a market cap or net worth of $40.45 million. The enterprise value is $123.56 million.

Market Cap	40.45M
Enterprise Value	123.56M

Important Dates

The next estimated earnings date is Tuesday, August 11, 2026, before market open.

Earnings Date	Aug 11, 2026
Ex-Dividend Date	n/a

Share Statistics

BTAI has 30.88 million shares outstanding. The number of shares has increased by 417.97% in one year.

Current Share Class	30.88M
Shares Outstanding	30.88M
Shares Change (YoY)	+417.97%
Shares Change (QoQ)	+7.85%
Owned by Insiders (%)	0.63%
Owned by Institutions (%)	5.68%
Float	26.36M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	59.48
Forward PS	29.66
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	181.70
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.62

Current Ratio	0.62
Quick Ratio	0.32
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-2.93

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-86.77%
Return on Invested Capital (ROIC)	-602.76%
Return on Capital Employed (ROCE)	240.31%
Weighted Average Cost of Capital (WACC)	11.37%
Revenue Per Employee	$23,448
Profits Per Employee	-$2.60M
Employee Count	29
Asset Turnover	0.02
Inventory Turnover	0.76

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -36.10% in the last 52 weeks. The beta is 0.32, so BTAI's price volatility has been lower than the market average.

Beta (5Y)	0.32
52-Week Price Change	-36.10%
50-Day Moving Average	1.18
200-Day Moving Average	1.73
Relative Strength Index (RSI)	59.36
Average Volume (20 Days)	636,397

Short Selling Information

The latest short interest is 3.53 million, so 11.42% of the outstanding shares have been sold short.

Short Interest	3.53M
Short Previous Month	3.56M
Short % of Shares Out	11.42%
Short % of Float	13.38%
Short Ratio (days to cover)	4.80

Income Statement

In the last 12 months, BTAI had revenue of $680,000 and -$75.33 million in losses. Loss per share was -$4.46.

Revenue	680,000
Gross Profit	247,000
Operating Income	-50.39M
Pretax Income	-75.33M
Net Income	-75.33M
EBITDA	-50.11M
EBIT	-50.39M
Loss Per Share	-$4.46

Full Income Statement

Balance Sheet

The company has $17.18 million in cash and $100.29 million in debt, giving a net cash position of -$83.11 million or -$2.69 per share.

Cash & Cash Equivalents	17.18M
Total Debt	100.29M
Net Cash	-83.11M
Net Cash Per Share	-$2.69
Equity (Book Value)	-105.54M
Book Value Per Share	-3.90
Working Capital	-21.09M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-57.38M
Capital Expenditures	n/a
Depreciation & Amortization	282,000
Net Borrowing	-8.11M
Free Cash Flow	-57.38M
FCF Per Share	-$1.86

Full Cash Flow Statement

Margins

Gross Margin	36.32%
Operating Margin	-7,410.44%
Pretax Margin	-11,078.53%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BTAI does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-417.97%
Shareholder Yield	-417.97%
Earnings Yield	-186.24%
FCF Yield	-141.86%

Analyst Forecast

The average price target for BTAI is $14.00, which is 968.70% higher than the current price. The consensus rating is "Buy".

Price Target	$14.00
Price Target Difference	968.70%
Analyst Consensus	Buy
Analyst Count	4
Revenue Growth Forecast (3Y)	361.98%
EPS Growth Forecast (3Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on February 10, 2025. It was a reverse split with a ratio of 1:16.

Last Split Date	Feb 10, 2025
Split Type	Reverse
Split Ratio	1:16

Scores

BTAI has an Altman Z-Score of -35.62 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-35.62
Piotroski F-Score	3